New Delhi, Oct. 16 -- Alphabet CEO Sundar Pichai on Wednesday shared an "exciting milestone" achieved by DeepMind's Gemma. The AI model, in a research collaboration with Yale University, developed a new pathway for potential cancer therapy.

In a post on X, the Google CEO announced that the tech giant had developed a new cancer-therapy hypothesis.

"An exciting milestone for AI in science: Our C2S-Scale 27B foundation model, built with @Yale and based on Gemma, generated a novel hypothesis about cancer cellular behavior, which scientists experimentally validated in living cells," he wrote.

"With more preclinical and clinical tests, this discovery may reveal a promising new pathway for developing therapies to fight cancer," Pichai added....